我国生物医药产业发展水平的因子分析法实证研究

目的:为生物医药产业相关部门提供决策依据和参考。方法:利用因子分析法构建生物医药产业发展水平的综合评价体系,从规模水平、盈利能力、营运能力和发展能力4个角度选取14个经济指标,客观评价我国28个地区的生物医药产业发展水平。结果与结论:我国生物医药产业各地区之间和地区内部不同角度之间发展水平均不平衡,发展规模水平对于提高生物医药产业发展水平十分重要,而盈利能力、营运能力、发展能力对综合发展水平也有一定贡献。各地区在未来的发展过程中,应认清自身优势、劣势,采取有效措施,促进生物医药产业健康发展。建议扩大产业规模,推动产业持续稳定增长;加大研发力度,高效管理。

Empirical Study by Factor Analysis in Biomedical Industry Development in China

OBJECTIVE： To provide a reference for the relevant biomedical industry departments which intend to take measures. METHODS： Factor analysis was used to construct the comprehensive evaluation system for biomedical industry development of 28 areas. The development of biomedical industry in China was evaluated by 14 economic indicators from scale level, profitability, operation capacity and development capacity. RESULTS ＆ CONCLUSIONS： The level of biomedical industry development of each area is not balanced. Scale level is important to improve the level of biomedical industry development, and profitability, operation capacity and development capacity also contribute to comprehensive development. Recognizing the advantages and disadvantage and taking relevant measures are crucial for each area to develop biomedical industry in healthy way in the future. It is suggested to enlarge the scale of biomedical industry, promote the sustained and steady growth of biomedical industry, strengthen research and develop effective management.